Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.

Breast cancer (Tokyo, Japan) - 1 May 2020

Acun Tolga, Senses Kerem Mert

Abstract excerpt

BACKGROUND: DNAJC10 (ERDJ5), a member of HSP40 family, was considered as an anti-oncogenic gene in neuroblastoma, prostate and colon cancers. But, the role and importance of DNAJC10 gene in breast cancer is currently unknown. In this study, in vitro/in vivo expression, biomarker potential and genetic/epigenetic alterations of DNAJC10 were analyzed in breast cancer. METHODS: Real-time qRT-PCR and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Down-Regulation
Share to Follow-Up Studies
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to DNA Methylation

Share to Gene Expression Regulation, Neoplastic

Share to HSP40 Heat-Shock Proteins

Share to Survival Rate

Source

Identifiers

PMID: 31902119
DOI: 10.1007/s12282-019-01042-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.PMID 31902119Read ↗

Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients.Semantic proximity Read ↗

Identification of DNAJC24 as a potential therapeutic target in breast cancerSemantic proximity Read ↗

Upregulation of the double-stranded RNA binding protein DGCR8 in invasive ductal breast carcinoma.Semantic proximity Read ↗

DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast CancerSemantic proximity Read ↗

High expression of DNAJA1 (HDJ2) predicts unfavorable survival outcomes in breast cancer.Semantic proximity Read ↗

DNAJB4 molecular chaperone distinguishes WT from mutant E-cadherin, determining their fate in vitro and in vivo.Semantic proximity Read ↗

The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomasSemantic proximity Read ↗

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcomeSemantic proximity Read ↗

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.Semantic proximity Read ↗

Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancerSemantic proximity Read ↗

Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer.Semantic proximity Read ↗

Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.